511 related articles for article (PubMed ID: 8024260)
21. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
22. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.
Vielhaber S; Jakubiczka S; Gaul C; Schoenfeld MA; Debska-Vielhaber G; Zierz S; Heinze HJ; Niessen HG; Kaufmann J
Muscle Nerve; 2006 Aug; 34(2):145-52. PubMed ID: 16642499
[TBL] [Abstract][Full Text] [Related]
23. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
Aydinli N; Calişkan M; Calay M; Ozmen M
Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
[TBL] [Abstract][Full Text] [Related]
24. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
25. Brain involvement in rheumatoid arthritis: a magnetic resonance spectroscopy study.
Emmer BJ; van der Bijl AE; Huizinga TW; Breedveld FC; Steens SC; Th Bosma GP; van Buchem MA; van der Grond J
Arthritis Rheum; 2009 Nov; 60(11):3190-5. PubMed ID: 19877035
[TBL] [Abstract][Full Text] [Related]
26. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
27. Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis.
Bertinotti L; Mortilla M; Conforti ML; Colangelo N; Nacci F; Del Rosso A; Fonda C; Casale R; Matucci-Cerinic M; Pignone A
J Rheumatol; 2006 Mar; 33(3):546-51. PubMed ID: 16511924
[TBL] [Abstract][Full Text] [Related]
28. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
[TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma.
Aaen GS; Holshouser BA; Sheridan C; Colbert C; McKenney M; Kido D; Ashwal S
Pediatrics; 2010 Feb; 125(2):295-303. PubMed ID: 20123781
[TBL] [Abstract][Full Text] [Related]
31. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
Pfefferbaum A; Adalsteinsson E; Spielman D; Sullivan EV; Lim KO
Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
[TBL] [Abstract][Full Text] [Related]
32. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
[TBL] [Abstract][Full Text] [Related]
33. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
[TBL] [Abstract][Full Text] [Related]
34. Proton magnetic resonance spectroscopy of the motor cortex in cervical myelopathy.
Kowalczyk I; Duggal N; Bartha R
Brain; 2012 Feb; 135(Pt 2):461-8. PubMed ID: 22180462
[TBL] [Abstract][Full Text] [Related]
35. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.
Pouwels PJ; Brockmann K; Kruse B; Wilken B; Wick M; Hanefeld F; Frahm J
Pediatr Res; 1999 Oct; 46(4):474-85. PubMed ID: 10509371
[TBL] [Abstract][Full Text] [Related]
36. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
Laubenberger J; Bayer S; Thiel T; Hennig J; Langer M
Rofo; 1998 Jun; 168(6):539-49. PubMed ID: 9687944
[TBL] [Abstract][Full Text] [Related]
37. MR spectroscopic evaluation of psychomotor delay of unknown cause in children.
Kosucu P; Erdemli S; Sönmez M; Kul S; Aksoy A
AJR Am J Roentgenol; 2010 Apr; 194(4):1110-5. PubMed ID: 20308519
[TBL] [Abstract][Full Text] [Related]
38. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
39. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
40. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy.
Hanefeld F; Holzbach U; Kruse B; Wilichowski E; Christen HJ; Frahm J
Neuropediatrics; 1993 Oct; 24(5):244-8. PubMed ID: 8309512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
